Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 1
1991 1
1992 2
1993 1
1994 2
1995 2
1996 7
1997 3
1998 4
1999 5
2000 7
2001 7
2002 3
2003 1
2004 2
2005 5
2006 8
2007 8
2008 12
2009 10
2010 10
2011 7
2012 8
2013 4
2014 12
2015 20
2016 18
2017 28
2018 21
2019 42
2020 46
2021 29
2022 41
2023 44
2024 44

Text availability

Article attribute

Article type

Publication date

Search Results

411 results

Results by year

Filters applied: . Clear all
Page 1
Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan.
Hulshof EC, Deenen MJ, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, Houwink EJF, Risselada A, Rongen GAPJM, van Schaik RHN, Touw DJ, van der Weide J, van Westrhenen R, Deneer VHM, Guchelaar HJ, Swen JJ. Hulshof EC, et al. Among authors: touw dj. Eur J Hum Genet. 2023 Sep;31(9):982-987. doi: 10.1038/s41431-022-01243-2. Epub 2022 Nov 28. Eur J Hum Genet. 2023. PMID: 36443464 Free PMC article. Review.
Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review.
Appeldoorn TYJ, Munnink THO, Morsink LM, Hooge MNL, Touw DJ. Appeldoorn TYJ, et al. Among authors: touw dj. Clin Pharmacokinet. 2023 Apr;62(4):559-571. doi: 10.1007/s40262-023-01225-7. Epub 2023 Mar 31. Clin Pharmacokinet. 2023. PMID: 37000342 Free PMC article.
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.
Beunk L, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, Guchelaar HJ, Houwink EJF, Risselada A, Rongen GAPJM, van Schaik RHN, Swen JJ, Touw D, van Westrhenen R, Deneer VHM, van der Weide J. Beunk L, et al. Among authors: touw d. Eur J Hum Genet. 2024 Mar;32(3):278-285. doi: 10.1038/s41431-023-01347-3. Epub 2023 Mar 31. Eur J Hum Genet. 2024. PMID: 37002327
SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function.
Suijk DLS, van Baar MJB, van Bommel EJM, Iqbal Z, Krebber MM, Vallon V, Touw D, Hoorn EJ, Nieuwdorp M, Kramer MMH, Joles JA, Bjornstad P, van Raalte DH. Suijk DLS, et al. Among authors: touw d. Clin J Am Soc Nephrol. 2022 May;17(5):663-671. doi: 10.2215/CJN.11480821. Epub 2022 Mar 23. Clin J Am Soc Nephrol. 2022. PMID: 35322793 Free PMC article. Clinical Trial.
Saliva for Model Informed Precision Dosing.
Touw DJ. Touw DJ. Expert Rev Clin Pharmacol. 2023 Jul-Dec;16(8):687-689. doi: 10.1080/17512433.2023.2223969. Epub 2023 Jun 16. Expert Rev Clin Pharmacol. 2023. PMID: 37293857 No abstract available.
Reply.
Sharma PK, Willems TP, Touw DJ, Woudstra W, Erasmus ME, Ebels T. Sharma PK, et al. Among authors: touw dj. Ann Thorac Surg. 2017 Dec;104(6):2121-2122. doi: 10.1016/j.athoracsur.2017.04.066. Ann Thorac Surg. 2017. PMID: 29153793 No abstract available.
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial.
van Bommel EJM, Muskiet MHA, van Baar MJB, Tonneijck L, Smits MM, Emanuel AL, Bozovic A, Danser AHJ, Geurts F, Hoorn EJ, Touw DJ, Larsen EL, Poulsen HE, Kramer MHH, Nieuwdorp M, Joles JA, van Raalte DH. van Bommel EJM, et al. Among authors: touw dj. Kidney Int. 2020 Jan;97(1):202-212. doi: 10.1016/j.kint.2019.09.013. Epub 2019 Oct 10. Kidney Int. 2020. PMID: 31791665 Free article. Clinical Trial.
Pharmacokinetic Boosting of Kinase Inhibitors.
Westra N, Touw D, Lub-de Hooge M, Kosterink J, Oude Munnink T. Westra N, et al. Among authors: touw d. Pharmaceutics. 2023 Apr 5;15(4):1149. doi: 10.3390/pharmaceutics15041149. Pharmaceutics. 2023. PMID: 37111635 Free PMC article. Review.
411 results